-
VCI Global Acquires Large Stake in a US$1.1 Billion Valuation AI Technology Company
KUALA LUMPUR, Malaysia, June 24, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), has signed
-
VCI Global Acquires Large Stake in a US$1.1 Billion Valuation AI Technology Company
KUALA LUMPUR, Malaysia, June 24, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), has signed
-
Sonoco to Acquire Eviosys, Creating The World’s Leading Metal Food Can and Aerosol Packaging Platfor
Advances Sonoco’s Shareholder Value Creation Strategy Through Disciplined and High Return Capital Investment Transaction Value of Approximately $3
-
王红权星回应封杀风波!态度诚恳,不在互联网也坚持做公益
不久前百万级网红博主王红权星因“清朗行动“被封杀,在账号被封禁的同时伴随的是对他及家人恶意满满的谩骂,并有人虚构他在网络上的十几种身份… 账号被封之后
-
SC200x系列再添新成员!移远通信智能模组SC200V / SC200U系列正式发布
6月24日,全球领先的物联网整体解决方案供应商移远通信宣布,正式推出其两款4G智能模组产品——SC200V系列和SC200U系列。 本新闻稿包含多媒体。此处查看新闻稿全文
-
New Report Exposes the “Dark Underworld” of Illegal Tobacco Trade in Canada, France, the Philippines
Buying illegal tobacco products is in danger of becoming normalized, with 43% of adult smokers surveyed comfortable buying cigarettes, even if they
-
越南FPT集团跻身2023亚洲信息技术服务品牌价值50强名单
据全球领先的信息技术咨询公司Gartner发布的最新全球信息技术服务市场份额报告(Gartner® Market Share: Services, Worldwide), 按照营业收入的指标来计算,FPT集
-
Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (C
LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the
-
Bayer和Solynta合作在小农市场推广实生马铃薯种子
Bayer和Solynta已达成协议,在肯尼亚和印度市场合作推动实生马铃薯种子的商业化和分销。此次合作标志着Bayer进入2000万公顷的全球马铃薯市场,同时也是Bayer与开发优
-
Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Tr
Mezagitamab-Treated Patients Showed Rapid and Sustained Increases in Platelet Counts That Persisted 8 Weeks After the Last Dose Through to Week 161
-
ALS Therapy Development Institute利用Esri技术绘制临床试验地图
ALS试验导航仪为ALS患者提供搜索合格研究的简便方法 雷德兰斯,加利福尼亚州--(美国商业资讯)-- ALS Therapy Development Institute(ALS TDI)是一家致力于终结肌萎
-
PMC Biogenix宣布扩张和重组
特种脂肪酰胺和高价值生物基产品的领先可持续生产商PMC Biogenix宣布在韩国庆州新建并扩建Armoslip®工厂,从而将产能提高50%。该项目将于2024年末开工,并将于2026